2446055-29-2

2446055-29-2 structure
2446055-29-2 structure
  • Name: HSP90-IN-13
  • Chemical Name: HSP90-IN-13
  • CAS Number: 2446055-29-2
  • Molecular Formula: C26H21N5O3S
  • Molecular Weight: 483.54
  • Catalog: Signaling Pathways Apoptosis Apoptosis
  • Create Date: 2022-08-21 20:57:36
  • Modify Date: 2024-01-11 10:06:53
  • HSP90-IN-13 (compound 5k) is a highly potent HSP90 pan inhibitor with an IC50 value of 25.07 nM. HSP90-IN-13 has multi-target activity against EGFR, VEGFR-2 and Topoisomerase-2. HSP90-IN-13 causes cell cycle arrest at G2/M phase and induces apoptosis of MCF-7 cells through mitochondrial-mediated pathway[1].

Name HSP90-IN-13
Description HSP90-IN-13 (compound 5k) is a highly potent HSP90 pan inhibitor with an IC50 value of 25.07 nM. HSP90-IN-13 has multi-target activity against EGFR, VEGFR-2 and Topoisomerase-2. HSP90-IN-13 causes cell cycle arrest at G2/M phase and induces apoptosis of MCF-7 cells through mitochondrial-mediated pathway[1].
Related Catalog
Target

HSP90:25.07 nM (IC50)

Topoisomerase-2:25.85 nM (IC50)

EGFR:38.5 nM (IC50)

VEGFR-2:126.95 nM (IC50)

In Vitro HSP90-IN-13 (compound 5k) arrests the cell cycle on MCF-7 at a G2/M phase by 35.06% and induced apoptosis by 19.82%[1]. HSP90-IN-13 has anti-proliferative activity against HCT-116, Hela and MCF-7 cell lines with IC50s of 4.47 μM, 7.55 μM and 4.04 μM, respectively[1]. HSP90-IN-13 has potent multi-target inhibitory activities against EGFR, VEGFR-2 and Topoisomerase-2 with IC50 values of 38.5 nM, 126.95 nM and 25.85 nM, respectively[1].
References

[1]. El-Shafey HW, et al. Synthetic approaches, anticancer potential, HSP90 inhibition, multitarget evaluation, molecular modeling and apoptosis mechanistic study of thioquinazolinone skeleton: Promising antibreast cancer agent. Bioorg Chem. 2020 Aug;101:103987.

Molecular Formula C26H21N5O3S
Molecular Weight 483.54